Ladera Ranch and What the Science Actually Says About Pesticide Exposure

Six children and teenagers in Ladera Ranch have been diagnosed with Ewing sarcoma since 2013. Reporting by NBC Los Angeles has since identified roughly a dozen rare pediatric cancer cases across Ladera Ranch and neighboring Orange County communities. Ewing sarcoma affects about 200 children nationwide in a given year, which is what makes six cases in one master-planned community of this size so alarming to the families living there.

Parents have petitioned their community to re-examine its landscaping pesticide program, pointing to application records they say show an unusual volume and variety of products. The California Cancer Registry, the UC Irvine cancer center and the Orange County Agricultural Commissioner's office have agreed to review the data. First Assistant U.S. Attorney Bill Essayli has asked the EPA to investigate a possible connection.

Why cancer cluster investigations so rarely produce an answer

This is the part of the story that gets the least attention and matters the most for setting expectations. Goodman and colleagues at Emory reviewed two decades of cancer cluster investigations in the United States, published in Critical Reviews in Toxicology in 2012. Health departments conducted at least 2,876 such investigations between 1990 and 2011, the large majority prompted by community alarm rather than by surveillance data.

That record is not evidence that environmental causes are rare. It reflects how genuinely difficult these investigations are. Cancers have long latency periods, so the relevant exposure may have occurred years or decades before diagnosis. Residents move in and out. Historical exposure is usually reconstructed from records rather than measured. And small numbers of cases, however devastating, produce wide statistical uncertainty. Families in Ladera Ranch are asking a reasonable question. The honest answer is that the investigation may not resolve it, and that is a limitation of the method rather than a judgment about the concern.

What the research says about Ewing sarcoma specifically

Ewing sarcoma is understudied relative to more common childhood cancers, partly because it is rare and partly because cancer research funding weights treatment over causation. The disease is driven by a characteristic fusion of the EWSR1 gene, and its incidence varies sharply across ancestral populations, both of which point toward inherited susceptibility playing a substantial role.

Where environmental risk factors for Ewing sarcoma have been studied, pesticides represent the largest single body of evidence. That evidence is genuinely mixed. A national case-control study in Australia found roughly doubled risk where mothers had handled pesticides and insecticides. Other case-control work has examined parental occupational exposure with inconsistent results, and some studies found no significant association with pesticide exposure at all. Reviews of this literature consistently describe the overall evidence base as scarce, and no specific environmental or lifestyle factor is currently established as a cause of Ewing sarcoma.

Where the evidence is considerably stronger

Associations between pesticide exposure and childhood leukemia, non-Hodgkin lymphoma and certain brain tumors are far better established than anything specific to Ewing sarcoma. The most instructive study for thinking about residential proximity is the CHARGE study out of UC Davis, published by Shelton and colleagues in Environmental Health Perspectives in 2014, funded by the National Institute of Environmental Health Sciences.

CHARGE linked California Pesticide Use Report application records to the home addresses of 970 pregnant women and looked at neurodevelopmental outcomes in their children. Living within roughly a mile of organophosphate applications during pregnancy was associated with about a 60 percent increase in autism spectrum disorder risk. Third-trimester organophosphate proximity carried an odds ratio of 2.0, and second-trimester chlorpyrifos applications an odds ratio of 3.3, though that last figure has a wide confidence interval running from 1.5 to 7.4. Pyrethroid proximity before conception or in the third trimester was associated with odds ratios between 1.7 and 2.3.

The indoor question nobody has studied properly

Here is where our team's view goes beyond what any single study has demonstrated, and we want to be explicit that we are reasoning rather than reporting. If applications roughly a mile away in open air are detectable in health outcomes, the exposure profile inside a sealed residence deserves considerably more scrutiny than it currently receives. Indoors, there is no rainfall, no direct sunlight to drive photodegradation, and limited air exchange. Semi-volatile compounds partition into carpet, upholstery and settled dust, where they can persist long after the surface residue has dried.

Small children encounter that environment differently than adults do. They spend more time at floor level, they put their hands in their mouths, they breathe more air per kilogram of body weight, and their systems are still developing. None of this establishes harm from any particular product. It does suggest that the indoor exposure pathway is understudied relative to how much of it a typical child actually experiences.

How our team thinks about personal exposure decisions

We are a pesticide manufacturer, so treat the following as an interested party's view rather than neutral guidance. These are the questions we would ask about any application in a space where children spend time, including our own products.

• Ask what is actually being applied. In California, pesticide application records are frequently obtainable, and product labels list active ingredients and required re-entry intervals. A community that can answer this question is in a much better position than one that cannot.
• Ask whether the application is targeted or scheduled. Treating an identified pest problem is a different exposure decision than spraying on a recurring calendar regardless of pest pressure.
• Ask about persistence indoors specifically, not just the outdoor half-life on the label. They are frequently not the same number.
• Weigh the pest problem honestly. Untreated infestations carry their own health consequences, and the correct answer is rarely to do nothing.
• Understand what EPA 25(b) minimum risk actually means. It is a regulatory exemption based on an ingredient list, not a health finding, and not a guarantee of any particular safety outcome.

Our position is that families should be able to get a straight answer about what is being applied where their children play, and that the burden of demonstrating safety belongs with the people manufacturing and applying these products. That includes us. We would rather compete on published evidence than on the fear this story is generating, and we intend to keep publishing what the research shows even where it complicates our own position.

The families in Ladera Ranch are still waiting for answers, and the reviews now underway may or may not provide them. We will update this post as the EPA review and the state cancer registry work produce findings.